Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 56 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/11/2007


1.		Phase II/III Randomized Study of MP/MTX vs DCF/MP/MTX in Patients with Relapsed T-ALL or T-NHL Who Achieve Second Remission Following Induction with PVDA (PRED/VCR/DNR/ASP)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				21 and under				NCI				POG-8862 POG-8862

Last Modified: 11/26/2007


2.		Phase III Randomized Comparison of Alpha-Interferon vs Pentostatin in Splenectomized Patients with Active Hairy Cell Leukemia (Summary Last Modified 11/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 15				NCI				CLB-8582 SWOG-8694, CALGB-8582

Last Modified: 2/1/2006


3.		Phase III Randomized Comparison of 2'-Deoxycoformycin vs Alpha-Interferon in Adults with Previously Untreated Hairy Cell Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				SWOG-8691 CAN-NCIC-HL1, CLB-8791, EST-2487, INT-0073, HL1


4.		Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				NIP-03-007 NCT00254163

Last Modified: 2/11/2005 First Published: 12/1/2000


5.		Phase I/II Study of Pentostatin Followed By Related Allogeneic Stem Cell Transplantation in Patients With Advanced Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				Over 18				NCI, Pharmaceutical / Industry				UCLA-0001032 SUPERGEN-UCLA-000103201, NCI-G00-1879, NCT00006968


6.		Phase I/II Chemotherapy with 2'-Deoxycoformycin for Refractory Cutaneous T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified								NCI-82-C-150 NCI-NMOB-827

Last Modified: 10/1/1991


7.		Phase I/II Study of Pentostatin with CP (Chlorambucil/Prednisone) in Patients with B-Cell Chronic Lymphocytic Leukemia (Summary Last Modified 10/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				any age				NCI				EST-1488 EST-1488

Last Modified: 5/1/1994


8.		Phase I/II Study of Escalating-Dose IFF in Combination with IFN-A/DCF in Patients with Relapsed or Refractory Multiple Myeloma (Summary Last Modified 05/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				20 and over								MSKCC-93013 NCI-V93-0268


9.		Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Closed				Not specified				Other				ID00-132 NCT00506922

Last Modified: 4/12/2006 First Published: 1/1/1999


10.		Phase II Study of Pentostatin, Cyclophosphamide, and Rituximab in Patients With Previously Treated Intermediate- or High-Risk Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				MSKCC-98083 NCI-G98-1482, NCT00003658

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute